primary

Understanding the Nature of Forex Scams

Source Node:
Time Stamp: April 3, 2024 6:15 AM - Modified On: April 3, 2024 - Published By:
Source Cluster:
Republished By Plato

As the name implies, a scam is a deceptive scheme designed to steal your money. This strategy is not exclusive to any specific industry; it's a real threat even within the trading and financial sectors. Among the numerous scams out there, forex trading scams have gained notoriety. There are many ways these schemes operate, and while the methods may vary, the primary goal remains the same: to rob you of your hard-earned cash. Spotting Scams in an Influencer's Promises One of the most common strategies scammers use includes social media

Moxy.io Announces Strategic Investment from GDA Capital; Michael Gord to Lead Web3 Initiatives

Source Node:
Time Stamp: March 6, 2024 11:45 AM - Modified On: March 6, 2024 - Published By:
Source Cluster:
Republished By Plato

  Seattle, United States. Moxy.io, a blockchain powered tournament platform and infrastructure provider in the competitive gaming and web3 space, has officially announced a strategic investment from GDA Capital, a leading global digital asset and blockchain investment and capital markets advisory firm. This investment marks a significant milestone for Moxy, as Michael Gord, Founder and CEO of GDA Capital, will also be joining their team as the Head of Web3. Michael Gord's appointment is a testament to the depth of GDA Capital's involvement in Moxy's future. Gord, a seasoned web3

Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries

Source Node:
Time Stamp: February 2, 2024 2:30 PM - Modified On: February 2, 2024 - Published By:
Source Cluster:
Republished By Plato

  New York, Feb 2, 2024 - (Plato Data)- Fortress Biotech (Fortress Bio), a unique biotech company led by industry veteran Dr. Lindsay Rosenwald, focused on identifying, in-licensing and developing high-potential marketed drugs and development-stage drug candidates in-house and through its subsidiary partner companies, has announced multiple new milestones to start 2024 with a bang. Avenue Therapeutics Finalizes Phase 3 Study for IV Tramadol with FDA Avenue Therapeutics, a subsidiary of Fortress Bio, has reached a significant milestone in its quest to introduce new therapies for neurologic diseases. The company

Unveiling the Inaugural Global Protocol Report: A Comprehensive Analysis of Blockchain Protocols that is Poised to Aid WEB3 Decisions

Source Node:
Time Stamp: January 22, 2024 4:41 AM - Modified On: January 22, 2024 - Published By:
Source Cluster:
Republished By Plato

Crypto Oasis, Crypto Valley, the DLT Science Foundation and Inacta Ventures Join Forces in a Groundbreaking Initiative that Will Help Navigate the Blockchain Trilemma Highlights: The report has unprecedented transparency and clarity, granular insights, and an evolving analysis of DLT protocol attributes. It will help industry experts and novices gain foundational knowledge on DLT concepts, WEB3 ecosystem infrastructure, the evolution of the Blockchain landscape, and the role of capital, talent, infrastructure, and regulations in WEB3 innovation. The Global Protocol Report introduces a comprehensive framework for assessing the maturity of DLT

SydTek DAO and TCG World: Revolutionizing Education in the Metaverse with AI-Based Interactive Learning

Source Node:
Time Stamp: October 23, 2023 1:28 PM - Modified On: October 23, 2023 - Published By:
Source Cluster:
Republished By Plato

Lewes DE, October 23, 2023. SydTek DAO is on a mission to reshape the landscape of education, harnessing the power of blockchain technology and the Metaverse to make learning accessible to all. One of its most exciting partnerships is with TCG World, where it plans to establish its primary Metaverse campus. This collaboration represents a significant leap forward in bringing education to the masses within this innovative digital realm. SydTek DAO has its roots in a diverse team of educators, technologists, and blockchain enthusiasts. United by a common vision, they

Gate Web3 Startup Announces Exciting New Project Listing: Game Verse

Source Node:
Time Stamp: October 19, 2023 7:20 AM - Modified On: October 19, 2023 - Published By:
Source Cluster:
Republished By Plato

Oct 18th - Gate Web3 Startup, a pioneering platform for innovative blockchain projects, is thrilled to announce the listing of a new project: Game Verse.  The Game Verse airdrop commences on October 18, 2023, at 7:00 UTC and concludes on October 23, 2023, at 7:00 UTC.  Game Verse's latest offering, Sword and Magic World, is a free-to-play MMORPG designed to captivate players with its vast open-world experiences. The game finds its roots in the rich legacy of Game Verse, a trailblazing global GameFi and Metaverse platform. Founded by the stalwarts

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

Source Node:
Time Stamp: October 13, 2023 5:16 AM - Modified On: October 13, 2023 - Published By:
Source Cluster:
Republished By Plato

In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis in

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Source Node:
Time Stamp: September 20, 2023 8:36 AM - Modified On: September 20, 2023 - Published By:
Source Cluster:
Republished By Plato

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

Bridging Real and Virtual Economies

Source Node:
Time Stamp: July 11, 2023 3:41 PM - Modified On: July 11, 2023 - Published By:
Source Cluster:
Republished By Plato

In an era where decentralized finance (DeFi) promises revolutionary, permissionless, and credit-check-free access to financial services, the limitations to its application lie in the narrow range of digital assets it encompasses. But industry pioneers are working to widen its scope by introducing real-world assets (RWAs) to the digital realm. For instance, in collaboration with the Hong Kong Monetary Authority (HKMA), Ripple is embarking on a research project to try and tokenize real estate. This venture was made public about seven weeks ago as part of a broader initiative, the digital

Stablecoins Under Scrutiny

Source Node:
Time Stamp: July 1, 2023 9:37 AM - Modified On: July 1, 2023 - Published By:
Source Cluster:
Republished By Plato

Amidst the market’s recovery from the recent onslaught of SEC crackdowns, rumors swirl over the potential targeting of stablecoins in their crosshairs. Such a move could have profound implications for cryptocurrency prices, making it crucial to gauge the likelihood of this scenario and the approach regulators might adopt. The largest stablecoins by market cap are Tether’s USDT and Circle’s USDC. Both are pegged to the US dollar and backed by various assets, typically highly liquid instruments like US Treasury bills. In theory, when someone wants to buy stablecoins from an